Tags

Type your tag names separated by a space and hit enter

Efficacy and safety of oral sildenafil citrate (Viagra) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter, placebo-controlled study.
Int J Impot Res. 2002 Aug; 14 Suppl 2:S42-7.IJ

Abstract

The objective of this work was to assess the efficacy and safety of sildenafil in patients with erectile dysfunction (ED) from Colombia, Ecuador, and Venezuela. One hundred and fifty-eight outpatients with ED participated in a double-blind, flexible-dose, randomized-controlled trial. Efficacy measures included question 3 (achieving an erection) and question 4 (maintaining an erection) from the International Index of Erectile Function (IIEF), the five functional domains of the IIEF, a global efficacy question, and patient event log. Sildenafil increased patients' ability to achieve/maintain erections (P<0.01). Seventy-seven per cent of sildenafil- vs 46% of placebo-treated patients reported improved erections (P<0.001). Sixty-five percent and 35% of intercourse attempts were successful among sildenafil and placebo patients, respectively (P<0.05). Sildenafil patients showed significant improvements in three of the five IIEF functional domains (P<0.05). Adverse events were reported for 51% and 33% of sildenafil and placebo patients, respectively. It can be concluded that sildenafil is an effective, well-tolerated treatment for ED in patients from Latin America.

Authors+Show Affiliations

Fundación Santafé de Bogotá, Bogotá, Colombia. fgomezj@elsitio.net.coNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

12161767

Citation

Gómez, F, et al. "Efficacy and Safety of Oral Sildenafil Citrate (Viagra) in the Treatment of Male Erectile Dysfunction in Colombia, Ecuador, and Venezuela: a Double-blind, Multicenter, Placebo-controlled Study." International Journal of Impotence Research, vol. 14 Suppl 2, 2002, pp. S42-7.
Gómez F, Davila H, Costa A, et al. Efficacy and safety of oral sildenafil citrate (Viagra) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter, placebo-controlled study. Int J Impot Res. 2002;14 Suppl 2:S42-7.
Gómez, F., Davila, H., Costa, A., Acuña, A., Wadskier, L. A., & Plua, P. (2002). Efficacy and safety of oral sildenafil citrate (Viagra) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter, placebo-controlled study. International Journal of Impotence Research, 14 Suppl 2, S42-7.
Gómez F, et al. Efficacy and Safety of Oral Sildenafil Citrate (Viagra) in the Treatment of Male Erectile Dysfunction in Colombia, Ecuador, and Venezuela: a Double-blind, Multicenter, Placebo-controlled Study. Int J Impot Res. 2002;14 Suppl 2:S42-7. PubMed PMID: 12161767.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Efficacy and safety of oral sildenafil citrate (Viagra) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter, placebo-controlled study. AU - Gómez,F, AU - Davila,H, AU - Costa,A, AU - Acuña,A, AU - Wadskier,L A, AU - Plua,P, AU - ,, PY - 2002/8/6/pubmed PY - 2003/1/23/medline PY - 2002/8/6/entrez SP - S42 EP - 7 JF - International journal of impotence research JO - Int. J. Impot. Res. VL - 14 Suppl 2 N2 - The objective of this work was to assess the efficacy and safety of sildenafil in patients with erectile dysfunction (ED) from Colombia, Ecuador, and Venezuela. One hundred and fifty-eight outpatients with ED participated in a double-blind, flexible-dose, randomized-controlled trial. Efficacy measures included question 3 (achieving an erection) and question 4 (maintaining an erection) from the International Index of Erectile Function (IIEF), the five functional domains of the IIEF, a global efficacy question, and patient event log. Sildenafil increased patients' ability to achieve/maintain erections (P<0.01). Seventy-seven per cent of sildenafil- vs 46% of placebo-treated patients reported improved erections (P<0.001). Sixty-five percent and 35% of intercourse attempts were successful among sildenafil and placebo patients, respectively (P<0.05). Sildenafil patients showed significant improvements in three of the five IIEF functional domains (P<0.05). Adverse events were reported for 51% and 33% of sildenafil and placebo patients, respectively. It can be concluded that sildenafil is an effective, well-tolerated treatment for ED in patients from Latin America. SN - 0955-9930 UR - https://www.unboundmedicine.com/medline/citation/12161767/Efficacy_and_safety_of_oral_sildenafil_citrate__Viagra__in_the_treatment_of_male_erectile_dysfunction_in_Colombia_Ecuador_and_Venezuela:_a_double_blind_multicenter_placebo_controlled_study_ L2 - http://dx.doi.org/10.1038/sj.ijir.3900897 DB - PRIME DP - Unbound Medicine ER -